These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 2098973

  • 1. [The inactivation of glucocorticosteroid hormones by rifampicin when it is used intermittently].
    Basov PV, Prokhorov NN, Spesivtsev OG.
    Vrach Delo; 1990 Nov; (11):20-2. PubMed ID: 2098973
    [Abstract] [Full Text] [Related]

  • 2. [Inactivation of glucocorticoid hormones by rifampicin in the treatment of patients with pulmonary tuberculosis].
    Spesivtsev OG, Basov PV.
    Probl Tuberk; 1988 Nov; (12):27-8. PubMed ID: 3244680
    [No Abstract] [Full Text] [Related]

  • 3. [The effect of rifampicin on the metabolism of glucocorticosteroid hormones in patients with tuberculosis].
    Basov PV, Galćhanskaia LD, Spesivtsev OG, Khokhlova EP, Ivutina VP.
    Probl Tuberk; 1994 Nov; (1):21-3. PubMed ID: 8170904
    [Abstract] [Full Text] [Related]

  • 4. Serum concentration of isoniazid following administration of the drug alone and in combination with rifampicin in patients of pulmonary tuberculosis.
    Singhal KC, Rathi R, Kishore K, Varshney SC, Varshney DP.
    Indian J Physiol Pharmacol; 1986 Nov; 30(1):115-7. PubMed ID: 3818028
    [No Abstract] [Full Text] [Related]

  • 5. Adrenal function during tuberculous infection and effects of antituberculosis treatment on endogenous and exogenous steroids.
    Keven K, Uysal AR, Erdogan G.
    Int J Tuberc Lung Dis; 1998 May; 2(5):419-24. PubMed ID: 9613639
    [Abstract] [Full Text] [Related]

  • 6. [Rifampicin pharmacokinetics in patients with destructive pulmonary tuberculosis].
    Karkishchenko NN, Vorob'ev VS, Khoron'ko VV, Anisimova NB, Chubarian VT.
    Vrach Delo; 1988 Dec; (12):72-3. PubMed ID: 3245176
    [No Abstract] [Full Text] [Related]

  • 7. [Effects of rifampicin and streptomycin on the concentrations of testosterone and cortisol in the blood of men (author's transl)].
    Nocke-Finck L, Breuer H, Reimers D.
    J Clin Chem Clin Biochem; 1980 Dec; 18(12):897-9. PubMed ID: 7205148
    [Abstract] [Full Text] [Related]

  • 8. [Relation between the efficacy of complex therapy of patients with destructive pulmonary tuberculosis and the duration of rifampicin administration].
    Sagalovich VIa, Manzhikova SR.
    Probl Tuberk; 1984 Oct; (10):51-4. PubMed ID: 6514699
    [No Abstract] [Full Text] [Related]

  • 9. [Pyridoxine metabolism in pulmonary tuberculosis patients under rifampicin therapy in combination with isoniazid].
    Baĭramaliev G, Krasheninnikova MA, Kolosovskaia VP, Chukanov VI.
    Probl Tuberk; 1982 Jan; (1):58-62. PubMed ID: 7058194
    [No Abstract] [Full Text] [Related]

  • 10. [Complex therapy of newly detected patients with destructive pulmonary tuberculosis using rifampicin and tuberculin].
    Reĭle EE, Polushkina EE.
    Probl Tuberk; 1987 Jan; (2):22-5. PubMed ID: 3575271
    [No Abstract] [Full Text] [Related]

  • 11. [Therapeutic possibilities of inhalation of rifampicin with dimexide in phthisiopulmonology].
    Gorbach IN, Samtsov VS.
    Probl Tuberk; 1991 Jan; (3):34-6. PubMed ID: 1871090
    [Abstract] [Full Text] [Related]

  • 12. [The short course therapies by Ryoken's method. 9 month and 12 month regimens including rifampicin (RFP) plus isoniazid (INH) in bacteriologically proved pulmonary tuberculosis].
    Gomi J, Aoyagi T, Fukuhara Y, Yamaguchi T, Matsumiya T.
    Kekkaku; 1985 Aug; 60(8):435-45. PubMed ID: 3906218
    [No Abstract] [Full Text] [Related]

  • 13. [Intravenous rifampicin therapy in open tuberculosis].
    Loos U, Musch E, Mackes KG, Reetz KP, Gläser R, Schwabe HK, Hengstmann J, Eichelbaum M.
    Med Welt; 1983 Jun 17; 34(24):701-3. PubMed ID: 6888237
    [No Abstract] [Full Text] [Related]

  • 14. On the pharmacokinetics of rifampicin I: Influence of dosage and duration of treatment with intermittent administration.
    Iwainsky H, Winsel K, Werner E, Eule H.
    Scand J Respir Dis; 1974 Jun 17; 55(4):229-36. PubMed ID: 4438983
    [No Abstract] [Full Text] [Related]

  • 15. Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis.
    Nijland HM, Ruslami R, Suroto AJ, Burger DM, Alisjahbana B, van Crevel R, Aarnoutse RE.
    Clin Infect Dis; 2007 Oct 15; 45(8):1001-7. PubMed ID: 17879915
    [Abstract] [Full Text] [Related]

  • 16. [In 76% of patients with active tuberculosis treated with triple therapy (isoniazid-rifampicin-pyrazinamide) cultural conversion precedes microscopic conversion].
    Nowak D, Radenbach D, Magnussen H.
    Pneumologie; 1990 Feb 15; 44 Suppl 1():497-8. PubMed ID: 2114634
    [Abstract] [Full Text] [Related]

  • 17. [Qualitative reaction for determining rifampicin in the urine for the purpose of controlling patient intake of this preparation].
    Tatarinova NV, Zhuk NA, Chukanov VI.
    Probl Tuberk; 1979 Aug 15; (8):62-5. PubMed ID: 482271
    [No Abstract] [Full Text] [Related]

  • 18. [Rifampicin and ethambutol treatment experience in chronic destructive pulmonary tuberculosis].
    Petrova GN, Sedunova EA, Korotaeva TA.
    Probl Tuberk; 1981 Mar 15; (3):73-4. PubMed ID: 7232397
    [No Abstract] [Full Text] [Related]

  • 19. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1980 Jan 15; 55(1):7-13. PubMed ID: 6988627
    [No Abstract] [Full Text] [Related]

  • 20. [The efficacy of the treatment of newly diagnosed patients with destructive tuberculosis of the lungs using rifampicin in combination with other drugs].
    Roslik SM, Pashkov IuN, Gerasimova TG, Marveeva SL.
    Probl Tuberk; 1990 Jan 15; (5):75-6. PubMed ID: 2388900
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.